Total submissions: 12
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Genetic Services Laboratory, |
RCV000502492 | SCV000594770 | uncertain significance | not specified | 2016-03-15 | criteria provided, single submitter | clinical testing | |
Center for Pediatric Genomic Medicine, |
RCV000514891 | SCV000610054 | uncertain significance | not provided | 2017-06-26 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV000766015 | SCV000897452 | uncertain significance | Hypogonadotropic hypogonadism 2 with or without anosmia; Jackson-Weiss syndrome; Pfeiffer syndrome; Hartsfield-Bixler-Demyer syndrome; Osteoglophonic dysplasia; Trigonocephaly 1; Encephalocraniocutaneous lipomatosis | 2018-10-31 | criteria provided, single submitter | clinical testing | |
Genomic Research Center, |
RCV000502492 | SCV000930355 | uncertain significance | not specified | 2019-04-27 | criteria provided, single submitter | clinical testing | |
Invitae | RCV001407682 | SCV001609659 | likely benign | Hypogonadotropic hypogonadism 2 with or without anosmia; Pfeiffer syndrome | 2023-12-13 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000514891 | SCV001793668 | likely benign | not provided | 2019-06-07 | criteria provided, single submitter | clinical testing | In silico analysis, which includes protein predictors and evolutionary conservation, supports that this variant does not alter protein structure/function; This variant is associated with the following publications: (PMID: 16838304, 14513299, 19056490, 11173846, 24127277, 23329143, 27896051, 15793702) |
Institute for Clinical Genetics, |
RCV000514891 | SCV002011023 | uncertain significance | not provided | 2021-11-03 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV004532374 | SCV004730697 | likely benign | FGFR1-related disorder | 2023-12-08 | criteria provided, single submitter | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |
OMIM | RCV000017681 | SCV000037958 | pathogenic | Trigonocephaly 1 | 2005-05-01 | no assertion criteria provided | literature only | |
Department of Pathology and Laboratory Medicine, |
RCV000514891 | SCV001552649 | uncertain significance | not provided | no assertion criteria provided | clinical testing | The FGFR1 p.Ile300Thr variant was identified in 1 of 10 patients with trigonocephaly but was not identified in 300 control chromosomes (Kress_2000_PMID: 11173846). The variant was also reported in 1 of 32 Antley-Bixler syndrome patients, however the patient with this variant was also compound heterozygous for two suspected pathogenic variants in the POR gene (Huang_2005_PMID: 15793702). The variant was identified in dbSNP (ID: rs121909633) and ClinVar (classified as uncertain significance by Fulgent Genetics, Children's Mercy Hospital, University of Chicago, and Shahid Beheshti University of Medical Sciences). The variant was identified in control databases in 84 of 280990 chromosomes at a frequency of 0.0002989 (Genome Aggregation Database March 6, 2019, v2.1.1). The variant was observed in the following populations: European (non-Finnish) in 78 of 128708 chromosomes (freq: 0.000606), Other in 3 of 7152 chromosomes (freq: 0.00042), African in 2 of 24216 chromosomes (freq: 0.000083) and East Asian in 1 of 19538 chromosomes (freq: 0.000051), but was not observed in the Latino, Ashkenazi Jewish, European (Finnish), or South Asian populations. The p.Ile300 residue is conserved in mammals but not in more distantly related organisms however four out of five computational analyses (PolyPhen-2, SIFT, AlignGVGD, BLOSUM, MutationTaster) do not suggest a high likelihood of impact to the protein; this information is not predictive enough to rule out pathogenicity. The variant occurs outside of the splicing consensus sequence and in silico or computational prediction software programs (SpliceSiteFinder, MaxEntScan, NNSPLICE, GeneSplicer) do not predict a difference in splicing. In summary, based on the above information the clinical significance of this variant cannot be determined with certainty at this time. This variant is classified as a variant of uncertain significance. | |
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, |
RCV000514891 | SCV001956046 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV000514891 | SCV001965678 | likely benign | not provided | no assertion criteria provided | clinical testing |